Evidence map›Paper›PMID 36833234›Full record

ArticleGenes2023

Association of

Antonio Sarría-Santamera, Kymbat Mukhtarova, Ardak Baizhaxynova, Kaznagul Kanatova, Saule Zhumambayeva, Ainur Akilzhanova, Azliyati Azizan

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Antonio Sarría-SantameraSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-5734-7468
Kymbat MukhtarovaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
Ardak BaizhaxynovaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
Kaznagul KanatovaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-8166-6514
Saule ZhumambayevaDepartment of Propedeutics of Children Disease, Astana Medical University, Astana 010000, Kazakhstan.
Ainur AkilzhanovaNational Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-6161-8355
Azliyati AzizanCollege of Osteopathic Medicine, Touro University Nevada, Henderson, NV 89014, USA.ORCID 0000-0003-1755-0490
Nazarbayev University · KZAstana Medical University · KZTouro University Nevada · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, SARS-CoV-2 was identified in Wuhan, China. Infection by SARS-CoV-2 causes coronavirus disease 2019 (COVID-19), which is characterized by fever, cough, dyspnea, anosmia, and myalgia in many cases. There are discussions about the association of vitamin D levels with COVID-19 severity. However, views are conflicting. The aim of the study was to examine associations of vitamin D metabolism pathway gene polymorphisms with symptomless COVID-19 susceptibility in Kazakhstan. The case-control study examined the association between asymptomatic COVID-19 and vitamin D metabolism pathway gene polymorphisms in 185 participants, who previously reported not having COVID-19, were PCR negative at the moment of data collection, and were not vaccinated. A dominant mutation in rs6127099 (

Indexed as

COVID-19Genetic Predisposition to DiseaseVitamin D3 24-HydroxylaseCase-Control StudiesHumansKazakhstanPolymorphism, Single NucleotideReceptors, CalcitriolSARS-CoV-2Vitamin DCYP24A1 protein, humanReceptors, CalcitriolVitamin DVitamin D3 24-HydroxylaseCOVID-19immune systemmetabolismSARS-CoV-2vitamin D

Identifiers

PMID36833234
PMCPMC9957291
OpenAlexW4317932831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.